NADPH competition by non-erythrose-reductase oxidoreductases limits erythritol yields in Yarrowia lipolytica , yet the specific contributors remain poorly defined. This study characterised two candidate genes, YALI0_F02013g (putative pyridoxine 4-dehydrogenase) and YALI0_A19910g (putative glycerol 2-dehydrogenase), using time-resolved transcriptomics, molecular docking and metabolic modelling. RNA-seq analysis across 96 h of fermentation revealed distinct temporal profiles: YALI0_F02013g was progressively induced 3.4-fold (peak 5040 FPKM at 72 h), while YALI0_A19910g was repressed 920-fold by 96 h (Table 2). Expression trends were validated by qRT-PCR (Pearson r > 0.94; Table 3). YALI0_A19910g expression correlated strongly negatively with erythritol titre (Pearson r = − 0.858), whereas YALI0_F02013g showed a weak positive correlation. Molecular docking predicted high NADPH binding affinities for both enzymes (− 9.8 and − 8.6 kcal mol⁻ 1 , respectively; Fig. 2) and identified conserved catalytic triads. An integrated prioritisation model ranked YALI0_F02013g as the higher-priority target (5.6/10 vs 5.0/10; Table 7). In silico flux estimates suggest that repressing YALI0_F02013g could conserve approximately 67% of the competing NADPH demand, potentially increasing erythritol yield by ~14%; these projections require experimental validation (Table 8). These findings identify YALI0_F02013g as a candidate metabolic bottleneck in the strain background examined, offering a specific target for engineering improved cofactor efficiency in industrial Yarrowia lipolytica strains.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: